Drug Substitution < Drug Therapy, Combination < Drug Users

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000957 (2010)	C William Wester [Botswana] ; Ann Muir Thomas ; Hermann Bussmann ; Sikhulile Moyo ; Joseph M. Makhema ; Tendani Gaolathe ; Vladimir Novitsky ; Max Essex ; Victor Degruttola ; Richard G. Marlink	Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.
000A63 (2010)	Salim S. Abdool Karim [Afrique du Sud] ; Kogieleum Naidoo ; Anneke Grobler ; Nesri Padayatchi ; Cheryl Baxter ; Andrew Gray ; Tanuja Gengiah ; Gonasagrie Nair ; Sheila Bamber ; Aarthi Singh ; Munira Khan ; Jacqueline Pienaar ; Wafaa El-Sadr ; Gerald Friedland ; Quarraisha Abdool Karim	Timing of initiation of antiretroviral drugs during tuberculosis therapy.
000C19 (2010)	Roland Landman [France] ; M B Diallo ; N F Ngom Gueye ; C Toure Kane ; S. Mboup ; M B Koita Fall ; B. Ndiaye ; G. Peytavin ; Y. Bennai ; A. Benalycherif ; P M Girard ; P S Sow	Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal.
000C31 (2010)	Jon Cohen	AIDS research. Bioethicists assail a celebrated TB/HIV treatment trial.
000C34 (2010)	Niel Malan [Afrique du Sud] ; Jun Su ; Marco Mancini ; Rong Yang ; Victoria Wirtz ; Judith Absalon ; Donnie Mcgrath	Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
000C41 (????)	Ernesto Hernández Pérez [Afrique du Sud] ; Halima Dawood	Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
000D01 (2010)	Doaa Elsherbiny [Suède] ; Yuan Ren ; Helen Mcilleron ; Gary Maartens ; Ulrika S H. Simonsson	Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.
000D25 (2010)	Jeremy Nuttall [États-Unis]	Microbicides in the prevention of HIV infection: current status and future directions.
000D92 (2010)	Edana Cassol [Afrique du Sud] ; Susan Malfeld ; Phetole Mahasha ; Schalk Van Der Merwe ; Sharon Cassol ; Chris Seebregts ; Massimo Alfano ; Guido Poli ; Theresa Rossouw	Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.
000E13 (2010)	P J Peters [États-Unis] ; J. Stringer ; M S Mcconnell ; J. Kiarie ; W. Ratanasuwan ; P. Intalapaporn ; D. Potter ; W. Mutsotso ; I. Zulu ; C B Borkowf ; O. Bolu ; J T Brooks ; P J Weidle	Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya.
000E88 (2010)	Elise Arrivé ; Marie-Laure Chaix ; Eric Nerrienet ; Stéphane Blanche ; Christine Rouzioux ; Divine Avit ; Leang Sim Kruy ; James Mcintyre ; Leakhena Say ; Glenda Gray ; Didier K. Ekouévi ; François Dabis	Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.
000F21 (2011)		Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
000F49 (2010)	B. Chevalier [France] ; J. Margery ; M. Sane ; P. Camara ; N. Lefebvre ; M. Gueye ; M. Thiam ; J-D Perrier-Gros-Claude ; F. Simon ; M. Fabre ; C. Soler ; V. Herve ; P S Mbaye ; J-M Debonne	[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
000F59 (2010)	Andrew Ratsela ; Michael Polis ; Sibongiseni Dhlomo ; Sean Emery ; Greg Grandits ; Paul Khabo ; Thandeka Khanyile ; Stephanus Komati ; James D. Neaton ; Lionel Chris David Naidoo ; Daphne Magongoa ; Duma Qolohle	A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
001060 (2010)	Landry Tsague [Rwanda] ; Fatima Oliveira Tsiouris ; Rosalind J. Carter ; Veronicah Mugisha ; Gilbert Tene ; Elevanie Nyankesha ; Stephania Koblavi-Deme ; Placidie Mugwaneza ; Eugenie Kayirangwa ; Ruben Sahabo ; Elaine J. Abrams	Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.
001118 (2011)	D Cristina Stefan [Afrique du Sud] ; David K. Stones ; Linda Wainwright ; Robert Newton	Kaposi sarcoma in South African children.
001215 (2010)	Quarraisha Abdool Karim [Afrique du Sud] ; Salim S. Abdool Karim ; Cheryl Baxter ; Gerald Friedland ; Tanuja Gengiah ; Andrew Gray ; Anneke Grobler ; Kogileum Naidoo ; Nesri Padayatchi ; Wafaa El-Sadr	The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
001333 (2012)	Sheree R. Schwartz [Afrique du Sud] ; Shruti H. Mehta ; Taha E. Taha ; Helen V. Rees ; Francois Venter ; Vivian Black	High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.
001896 (2012)	Charles R. Swanepoel [Afrique du Sud] ; Nicola Wearne ; Maureen S. Duffield ; Ikechi G. Okpechi	The evolution of our knowledge of HIV-associated kidney disease in Africa.
001A54 (2013)	Megan Palmer [Afrique du Sud] ; Matthew Chersich ; Harry Moultrie ; Louise Kuhn ; Lee Fairlie ; Tammy Meyers	Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa.
001B83 (2013)	Matthew G. Gartland [États-Unis] ; Namwinga T. Chintu ; Michelle S. Li ; Mwila K. Lembalemba ; Saziso N. Mulenga ; Maximillian Bweupe ; Patrick Musonda ; Elizabeth M. Stringer ; Jeffrey S A. Stringer ; Benjamin H. Chi	Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural Zambia.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Drug Therapy, Combination" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Therapy, Combination
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024